Efficacy and Tolerability of Riluzole in Treatment Resistant Depression
What is the purpose of this trial?
This study aims to examine the antidepressant efficacy of riluzole, employing a randomized, double-blind, placebo-controlled, adjunctive trial in treatment-resistant major depressive disorder (TRD).
- 18 Years - 65 Years
- Yale University
- June 2011
- Last Updated:
- January 15, 2014
- Study HIC#:
Clinicaltrials.gov ID: NCT01204918